Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
2021 · Science · 248 citations
https://doi.org/10.1126/science.abg5827
D
Dominique Missiakas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
236
Papers
16.9K
Citations
71
h-index
165
i10-index
Dominique Missiakas is an academic researcher from Howard University. The author has contributed to research in topics: Antimicrobial Resistance in Staphylococcus & Biochemical and Structural Characterization & Bacterial Genetics and Biotechnology. The author has an h-index of 71, co-authored 201 publications.
ORCID: 0000-0001-6482-9633Papers by this author
worksEvolution of immune genes is associated with the Black Death
2022 · Nature · 240 citations
https://doi.org/10.1038/s41586-022-05349-x
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
2022 · Nature Communications · 164 citations
https://doi.org/10.1038/s41467-021-27893-2
Signal peptides direct surface proteins to two distinct envelope locations of Staphylococcus aureus
2008 · The EMBO Journal · 119 citations
https://doi.org/10.1038/emboj.2008.185
Activation of Inhibitors by Sortase Triggers Irreversible Modification of the Active Site
2007 · Journal of Biological Chemistry · 111 citations
https://doi.org/10.1074/jbc.m701857200
The Capsular Polysaccharide of Staphylococcus aureus Is Attached to Peptidoglycan by the LytR-CpsA-Psr (LCP) Family of Enzymes
2014 · Journal of Biological Chemistry · 99 citations
https://doi.org/10.1074/jbc.m114.567669
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat